Literature DB >> 14983011

The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator.

Fajun Yang1, Rosalie DeBeaumont, Sharleen Zhou, Anders M Näär.   

Abstract

The human activator-recruited cofactor (ARC), a family of large transcriptional coactivator complexes related to the yeast Mediator, was recently identified based on functional association with the activation domains of multiple cellular and viral transcriptional activators, including the herpes simplex viral activator VP16, sterol regulatory element binding protein, and NF-kappaB. Here we describe the biochemical purification and cloning of the 92-kDa ARC/Mediator subunit, ARC92, that is specifically targeted by the activation domain of the VP16 transactivator. Affinity chromatography using the VP16 activation domain followed by peptide microsequencing led to the identification of ARC92 as a specific cellular interaction partner of the VP16 activation domain. ARC92 associates with the VP16 activation domain in vitro and in vivo, and the VP16 binding domain of ARC92 is a strong competitive inhibitor of Gal4-VP16 in vivo. Moreover, small interfering RNA-mediated knockdown of ARC92 in human cells results in selective inhibition of Gal4-VP16 gene activation. Taken together, our results suggest that ARC92 is a direct and specific target of the VP16 transactivator that serves in the context of the ARC/Mediator coactivator as an important transducer of transcription activating signals from the VP16 activation domain to the RNA polymerase II transcriptional machinery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14983011      PMCID: PMC356952          DOI: 10.1073/pnas.0308676100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleosome arrays.

Authors:  K E Neely; A H Hassan; A E Wallberg; D J Steger; B R Cairns; A P Wright; J L Workman
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action.

Authors:  M Ito; C X Yuan; H J Okano; R B Darnell; R G Roeder
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

3.  Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes.

Authors:  K Ikeda; D J Steger; A Eberharter; J L Workman
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

4.  Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein.

Authors:  T G Boyer; M E Martin; E Lees; R P Ricciardi; A J Berk
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Transcriptional activation by the acidic domain of Vmw65 requires the integrity of the domain and involves additional determinants distinct from those necessary for TFIIB binding.

Authors:  S Walker; R Greaves; P O'Hare
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

6.  Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.

Authors:  M Ito; C X Yuan; S Malik; W Gu; J D Fondell; S Yamamura; Z Y Fu; X Zhang; J Qin; R G Roeder
Journal:  Mol Cell       Date:  1999-03       Impact factor: 17.970

7.  Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.

Authors:  C Rachez; B D Lemon; Z Suldan; V Bromleigh; M Gamble; A M Näär; H Erdjument-Bromage; P Tempst; L P Freedman
Journal:  Nature       Date:  1999-04-29       Impact factor: 49.962

8.  Composite co-activator ARC mediates chromatin-directed transcriptional activation.

Authors:  A M Näär; P A Beaurang; S Zhou; S Abraham; W Solomon; R Tjian
Journal:  Nature       Date:  1999-04-29       Impact factor: 49.962

9.  Transcriptional activators direct histone acetyltransferase complexes to nucleosomes.

Authors:  R T Utley; K Ikeda; P A Grant; J Côté; D J Steger; A Eberharter; S John; J L Workman
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

10.  Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro.

Authors:  A M Näär; P A Beaurang; K M Robinson; J D Oliner; D Avizonis; S Scheek; J Zwicker; J T Kadonaga; R Tjian
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

View more
  67 in total

1.  MED16 and MED23 of Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators.

Authors:  Tae Whan Kim; Yong-Jae Kwon; Jung Mo Kim; Young-Hwa Song; Se Nyun Kim; Young-Joon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  Mechanism of Mediator recruitment by tandem Gcn4 activation domains and three Gal11 activator-binding domains.

Authors:  Eric Herbig; Linda Warfield; Lisa Fish; James Fishburn; Bruce A Knutson; Beth Moorefield; Derek Pacheco; Steven Hahn
Journal:  Mol Cell Biol       Date:  2010-03-22       Impact factor: 4.272

3.  PTOV1 is overexpressed in human high-grade malignant tumors.

Authors:  Sara Fernández; Jose L Mosquera; Lide Alaña; Alex Sanchez-Pla; Juan Morote; Santiago Ramón Y Cajal; Jaume Reventós; Inés de Torres; Rosanna Paciucci
Journal:  Virchows Arch       Date:  2010-12-23       Impact factor: 4.064

Review 4.  The mediator of RNA polymerase II.

Authors:  Erik Blazek; Gerhard Mittler; Michael Meisterernst
Journal:  Chromosoma       Date:  2005-02-03       Impact factor: 4.316

5.  Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex.

Authors:  Shinobu Yamamoto; Alexander Eletsky; Thomas Szyperski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

6.  Endoplasmic reticulum stress-responsive transcription factor ATF6α directs recruitment of the Mediator of RNA polymerase II transcription and multiple histone acetyltransferase complexes.

Authors:  Dotan Sela; Lu Chen; Skylar Martin-Brown; Michael P Washburn; Laurence Florens; Joan Weliky Conaway; Ronald C Conaway
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

7.  Role for human mediator subunit MED25 in recruitment of mediator to promoters by endoplasmic reticulum stress-responsive transcription factor ATF6α.

Authors:  Dotan Sela; Juliana J Conkright; Lu Chen; Joshua Gilmore; Michael P Washburn; Laurence Florens; Ronald C Conaway; Joan Weliky Conaway
Journal:  J Biol Chem       Date:  2013-07-17       Impact factor: 5.157

8.  ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.

Authors:  Simon L Currie; Jedediah J Doane; Kathryn S Evans; Niraja Bhachech; Bethany J Madison; Desmond K W Lau; Lawrence P McIntosh; Jack J Skalicky; Kathleen A Clark; Barbara J Graves
Journal:  J Mol Biol       Date:  2017-07-17       Impact factor: 5.469

9.  Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models.

Authors:  Alejandro Leal; Kathrin Huehne; Finn Bauer; Heinrich Sticht; Philipp Berger; Ueli Suter; Bernal Morera; Gerardo Del Valle; James R Lupski; Arif Ekici; Francesca Pasutto; Sabine Endele; Ramiro Barrantes; Corinna Berghoff; Martin Berghoff; Bernhard Neundörfer; Dieter Heuss; Thomas Dorn; Peter Young; Lisa Santolin; Thomas Uhlmann; Michael Meisterernst; Michael Werner Sereda; Michael Sereda; Ruth Martha Stassart; Gerd Meyer zu Horste; Klaus-Armin Nave; André Reis; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2009-03-17       Impact factor: 2.660

10.  VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection.

Authors:  Francisco J Herrera; Steven J Triezenberg
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.